Stock listing
NASDAQ:KZR Kezar Life Sciences, Inc. Stock
Home listing (NASDAQ) of Kezar Life Sciences, Inc.
Follow Kezar Life Sciences, Inc. into a list and get an email when it puts out news.

- Ticker
- NASDAQ:KZR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Mar 12, 2026
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Latest news
Kezar Life Sciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 76 in all · newest Mar 12, 2026 · oldest 2019
- Decks
- 8 decks · latest Nov 10, 2025
Where Kezar Life Sciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KZR · Home listing · This page | NASDAQ | United States | USD |
| Lang & Schwarz:A40NJT | Lang & Schwarz | Germany | EUR |
| LS Exchange:A40NJT | LS Exchange | Germany | EUR |
| BOATS:KZR | BOATS | United States | USD |
| Tradegate:2KZ0 | Tradegate | Germany | EUR |
| Frankfurt:2KZ0 | Frankfurt | Germany | EUR |
| gettex:2KZ0 | gettex | Germany | EUR |
| Munich:2KZ0 | Munich | Germany | EUR |
| Stuttgart:2KZ0 | Stuttgart | Germany | EUR |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (November 2025) | Technical | 14 slides | Nov 10, 2025 |
| Technical Presentation (March 2025) | Technical | 36 slides | Mar 25, 2025 |
| Technical Presentation (February 2025) | Technical | 33 slides | Feb 27, 2025 |
| Technical Presentation (2023) | Technical | 11 slides | 2023 |
| Investor Day (June 2022) | Investor day | 27 slides | Jun 27, 2022 |
| Investor Day (November 2021) | Investor day | 62 slides | Nov 15, 2021 |
| Technical Presentation (2020) | Technical | 6 slides | 2020 |
| Investor Presentation (October 2019) | Investor deck | 21 slides | Oct 3, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past) | Director · Since at least Jun 25, 2019 |
| Michael Kauffman Other companies: Kyntra Bio, Inc. (Director · Since at least Jun 4, 2025); Verastem, Inc. (President, Development · Since at least Nov 26, 2012); Adicet Bio, Inc. (Director · Nov 17, 2021 – Aug 21, 2024 · Past); Karyopharm Therapeutics Inc. (Director · Nov 5, 2013 – Feb 28, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jan 15, 2010 – Jun 6, 2013 · Past); Onyx Pharmaceuticals Inc (Chief Medical Officer · Nov 16, 2009 – Feb 9, 2010 · Past) | Director · Since at least Jun 20, 2018 |
| Noreen Henig Other companies: Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Lazard Growth Acquisition Corp I (Director · Feb 9, 2021 – Feb 9, 2021 · Past) | Chief Medical Officer · May 1, 2020 – Jul 24, 2023 · Past |
| Graham Cooper Other companies: Beam Therapeutics Inc. (Director · Since at least Jun 4, 2025) | Director · Since at least Jun 18, 2025 |
| Vassiliki Economides Other companies: Gritstone bio, Inc. (EVP, CHIEF FINANCIAL OFFICER · Jun 23, 2021 – Apr 4, 2025 · Past) | SVP, Strategy & External Aff. · Mar 4, 2019 – Mar 29, 2021 · Past |
| Christopher J Kirk | CEO, Director · Since at least Jun 20, 2018 |
| Courtney Wallace | Director · Since at least Dec 9, 2021 |
| Elizabeth Garner | Director · Since at least Dec 18, 2019 |
| Jason Dinges | Director · Jun 20, 2018 – Jun 28, 2021 · Past |
| John Franklin Fowler | Director · Since at least Jun 20, 2018 |
All 16 people
| Person | Seat |
|---|---|
| Marc Belsky | Chief Financial Officer · Since at least May 11, 2026 |
| Mark C Schiller | Chief Operating Officer · Since at least Mar 27, 2025 |
| Nicholas Michael Mordwinkin | Chief Business Officer · Jul 11, 2022 – Jan 7, 2024 · Past |
| Niti Goel | Chief Medical Officer · Jun 20, 2018 – Jan 6, 2019 · Past |
| Pichi Luo Chiang | SVP, Corporate Controller · Since at least Apr 1, 2025 |
| Zung Phuong To | Chief Development Officer · Since at least Apr 1, 2025 |
Log in to ask 6ix AI your own questions about Kezar Life Sciences, Inc.